Affiliation:
1. N.N. Blokhin National Medical Research Center of Oncology
2. A.I. Evdokimov Moscow State University of Medicine and Dentistry
Abstract
Introduction. Currently, there is no global consensus regarding the management of breast cancer patients with implant-associated infections. Some studies clearly recommend their removal and surgical debridement with consecutive antimicrobial treatment, while others prefer long-term antibacterial therapy (at least 1 month) with the effectiveness of such conservative approach of 36–73 %.Case description. A 43-year-old patient suffering from brca1-positive right breast cancer t2n0m0 (invasive carcinoma of non-specific type g3, er – 8, pgr – 0, her-2/neu – 0, ki67 (%) – less than 20 %), underwent radical skin-preserving mastectomy on the right with simultaneous implant reconstruction and preventive subcutaneous mastectomy on the left with simultaneous implant reconstruction. Peri-implant infection in the left breast was observed on the 21st day after surgery.Results. The patient received empirical therapy with cefepim. Microbiological examination of the punctate revealed the causative agent of infection – methicillin-resistant staphylococcus aureus (mrsa) (1×105cfu/ml). Daptomycin 6 mg/kg/day was added to therapy. After 8 weeks, the patient received oral moxifloxacin 400 once daily, for another 3 weeks. A complete response was achieved. The patient has no signs of infection for 3 years.Conclusion. Long-term etiotropic antibacterial therapy with daptomycin followed by oral moxifloxacin resulted in a stable clinical effect.
Publisher
Tomsk Cancer Research Institute
Reference10 articles.
1. Kaprin A.D., Starinskii V.V., Petrova G.V. Malignant neoplasms in Russia in 2017 (morbidity and mortality). Moscow, 2018. 250 p. (in Russian).
2. Letyagin V.P. Breast tumors. Mammology. 2005; 1: 14–22. (in Russian).
3. Zikiryakhodzhaev A.D., Sobolevskii V.A., Chistyakov S.S., Grebennokova O.P., Krokhina O.V., Anurova O.A., Iskenderov R.M., Azimova R.B., Shoua A.N. Reconstructive surgery and rehabilitation of breast cancer patients. Russian Medical Journal. Oncology. 2011; 2: 42. (in Russian).
4. Grigorievskaya Z.V., Petukhova I.N., Dyakova S.A., Dmitrieva N.V. Epidemiology of hospital-acquired infections caused by highly resistant strains in cancer patients. Siberian Journal of Oncology. 2016; 15(3): 62–66. (in Russian). doi: 10.21294/1814-4861-2016-15-3-62-66.
5. Grigorievskaya Z.V., Petukhova I.N., Bagirova N.S., Shilnikova I.I., Tereshchenko I.V., Grigorievsky E.D., Dmitrieva N.V. Nasocomial infectoions in cancer patients: problem of gram-negative bacterial resistance. Siberian Journal of Oncology. 2017; 16(1): 91–97. (in Russian). doi: 10.21294/1814-4861-2017-16-1-91-97.